FDA/CMS Summit is THE biopharma event that facilitates direct dialogue between biopharma executives, investors and FDA/CMS regulators to explain complex regulatory and reimbursement policy.
Cynthia Bens, the Alliance's Vice President of Public Policy, will be a panelist during the session on FDA and Patient Centeredness: A Work in Progress.
FDA and Patient Centeredness: A Work in Progress
Tuesday, December 15, 2015
11:45 a.m. – 12:30 p.m.
Through programs like the Patient-Focused Drug Development Initiative and a push for better use of patient-reported outcomes, FDA is increasingly soliciting the views of patients and advocacy groups. How is FDA incorporating these viewpoints into its drug reviews, and have the initiatives been a success? What tweaks are likely to come as part of the next round of user fee negotiations?
Nancy Myers, President and Founder, Catalyst Healthcare Consulting (moderator)
Patricia Furlong, President and CEO, Parent Project Muscular Dystrophy
Cynthia A. Bens, Vice President of Public Policy, Alliance for Aging Research
C. Grace Whiting, JD, Director, Strategic Partnerships, National Alliance for Caregiving
Lori Abrams, Director, Diversity & Patient Engagement, Global Clinical Operations, Bristol-Myers Squibb Co.
Marc Boutin, CEO, National Health Council